Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo-Eastern Plantations Regulatory News (AEP)

Share Price Information for Anglo-Eastern Plantations (AEP)

Share Price is delayed by 15 minutes
Get Live Data
1,530.00    -8.00 (-0.52%)
Bid:
1,540.00
Ask:
1,544.00
Spread: 4.00 (0.26%)
Market Cap: £586.90m
AEP Live PriceLast checked at - London Stock Exchange

Intraday Anglo-Eastern Plantations Share Chart

Interim Management Statement

19 May 2016 07:01

RNS Number : 6957Y
Anglo-Eastern Plantations PLC
19 May 2016
 

19 May 2016

Anglo-Eastern Plantations Plc

("AEP", "Group" or "Company")

 

Interim Management Statement

 

Anglo-Eastern Plantations Plc and its subsidiaries, which owns, operates and develops plantations in Indonesia and Malaysia, amounting to some 128,600 hectares producing mainly palm oil and some rubber of which approximately 65,200 hectares (including Plasma) are planted, today announces its Interim Management Statement in respect of the period since 31 December 2015.

 

 

Operational and financial performance

 

For the first three months ended 31 March 2016, our own production of fresh fruit bunches ("FFB") was 187,000mt, an increase of 9% compared to the same period in 2015 (3M15: 172,200mt). Increased production was in line with higher matured planting from the Kalimantan plantations. FFB bought-in was 110,800mt, which represents a decrease of 13% in comparison with the same period in 2015 (3M15: 127,900mt). Total Crude Palm Oil ("CPO") produced was 63,200mt, 9% higher than the corresponding period in 2015 (3M15: 58,200mt) due to better oil extraction rate.

 

CPO CIF Rotterdam price averaged $630/mt for the first three months to 31 March 2016. This represents a decrease of 6% from the average price of $669/mt recorded in the first quarter of 2015 but is above $560/mt being the price at the start of 2016.

 

The Group's balance sheet remains strong with the Company continuing to generate positive cash flow. The Company's Long Term Development Loans totalled $35.8m as at 31 March 2016 (31 March 2015: $34.9m). The increase is due to a loan drawdown in February 2016. The Group has net cash of $67.3m as at 31 March 2016.

 

 

Development

 

The Group's new planting for the three months ended 31 March 2016 totalled 186 hectares. As reported previously this was primarily due to delays in settlement with the villagers for land compensation payments. These negotiations are continuing and management is confident that some of these negotiations will be concluded successfully. The replanting of circa 1,500 hectares in North Sumatera will start in the second quarter of 2016 and should be completed by the year end.

 

The Biogas plant in Central Kalimantan is about 75% completed and expected to be operational by the start of fourth quarter of 2016. Civil works for a third Biogas plant within the Group has started in Bengkulu. This is in line with the Group's commitment to reduce its carbon foot prints.

 

 

Outlook

 

The CPO CIF Rotterdam price started the year at $560/mt and has been rising rapidly; it closed at $731/mt on 31 March 2016. The CPO price is expected to remain strong until at least the end of June 2016 due to concerns over weaker CPO supply resulting from the El-Nino effect and the heat wave experienced in Indonesia and Malaysia.

 

The improving crude oil prices will also enhance the competitiveness and development in biodiesel which will result in a higher demand for CPO.

 

 

 

 

 

 

For further enquiry, contact:

 

Anglo-Eastern Plantations Plc

Dato' John Lim Ewe Chuan

 +44 (0)20 7216 4621

Panmure Gordon

Andrew Godber

 

+44 (0)20 7886 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMKKLRGVZG
Date   Source Headline
25th Jun 20187:00 amRNSAGM Statement
22nd May 20187:49 amRNSTrading Statement
18th May 20187:00 amRNSAnnual Financial Report & Notice of AGM
24th Apr 201810:01 amRNSDividend Declaration
24th Apr 201810:00 amRNSPreliminary Results
8th Mar 20188:00 amRNSBlock listing Interim Review
8th Nov 20178:00 amRNSTrading Statement
8th Sep 20175:00 pmRNSBlock listing Interim Review
23rd Aug 20175:00 pmRNSInterim Results
27th Jun 20175:01 pmRNSDividend Declaration
27th Jun 20175:00 pmRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
26th May 20177:00 amRNSAnnual Financial Report
23rd May 201710:00 amRNSTrading Statement
26th Apr 20176:15 pmRNSDividend Declaration
26th Apr 20174:17 pmRNSDividend Declaration
26th Apr 201712:01 pmRNSPreliminary Results
9th Mar 201710:48 amRNSBlock listing Interim Review
15th Nov 20169:00 amRNSTrading Statement
6th Sep 20169:10 amRNSBlock listing Interim Review
25th Aug 20165:00 pmRNSInterim Results
28th Jun 201610:53 amRNSDividend Declaration
27th Jun 20165:48 pmRNSResult of AGM
27th Jun 20167:00 amRNSAGM Statement
27th May 201610:00 amRNSNotice of AGM and Annual Report
19th May 20167:01 amRNSInterim Management Statement
11th May 20164:40 pmRNSSecond Price Monitoring Extn
11th May 20164:35 pmRNSPrice Monitoring Extension
29th Apr 20165:12 pmRNSDividend Declaration
26th Apr 20164:00 pmRNSFinal Results
6th Apr 20164:40 pmRNSSecond Price Monitoring Extn
6th Apr 20164:35 pmRNSPrice Monitoring Extension
14th Mar 20165:28 pmRNSBlocklisting Interim Review
23rd Feb 20168:44 amRNSTrading Update
29th Jan 20164:40 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
18th Dec 20157:00 amRNSAdoption of FRS 101 - Reduced Disclosure Framework
18th Nov 201510:38 amRNSInterim Management Statement
5th Oct 20158:30 amRNSChange of Adviser
16th Sep 201510:08 amRNSBlocklisting Interim Review
27th Aug 20151:00 pmRNSHalf Yearly Report
18th Aug 201511:57 amRNSTrading Update
30th Jun 20158:30 amRNSResult of AGM
30th Jun 20158:30 amRNSDividend Declaration
29th Jun 20158:30 amRNSAGM Statement
29th May 20159:31 amRNSNotice of AGM
26th May 20159:48 amRNSInterim Management Statement
8th May 201510:30 amRNSDirectorate Change
30th Apr 20157:00 amRNSFinal Results
5th Mar 201510:10 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.